Abbott (NYSE:ABT) said its board of directors approved the spinout of its branded pharmaceuticals business as AbbVie Inc. in which Abbott’s shareholders will receive an AbbVie share for each ABT share they own.

The distribution is slated for Jan. 1, 2013, for shareholders of record as of Dec. 12, according to a press release.